Efficiency of non-invasive prenatal screening in pregnant women at advanced maternal age

BMC Pregnancy Childbirth. 2021 Jan 26;21(1):86. doi: 10.1186/s12884-021-03570-6.

Abstract

Background: Non-invasive prenatal screening (NIPS) is widely used as the alternative choice for pregnant women at high-risk of fetal aneuploidy. However, whether NIPS has a good detective efficiency for pregnant women at advanced maternal age (AMA) has not been fully studied especially in Chinese women.

Methods: Twenty-nine thousand three hundred forty-three pregnant women at AMA with singleton pregnancy who received NIPS and followed-up were recruited. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV), receiver operating characteristic (ROC) curves and the Youden Index for detecting fetal chromosomal aneuploidies were analyzed. The relationship between maternal age and common fetal chromosomal aneuploidy was observed.

Results: The sensitivity, specificity, PPV, NPV of NIPS for detecting fetal trisomy 21 were 99.11, 99.96, 90.98, and 100%, respectively. These same parameters for detecting fetal trisomy 18 were 100, 99.94, 67.92, and 100%, respectively. Finally, these parameters for detecting trisomy 13 were 100, 99.96, 27.78, and 100%, respectively. The prevalence of fetal trisomy 21 increased exponentially with maternal age. The high-risk percentage incidence rate of fetal trisomy 21 was significantly higher in the pregnant women at 37 years old or above than that in pregnant women at 35 to 37 years old. (Youden index = 37).

Conclusion: It is indicated that NIPS is an effective prenatal screening method for pregnant women at AMA.

Keywords: Advanced maternal age (AMA); Fetal chromosomal aneuploidies; Non-invasive prenatal screening (NIPS); Prenatal screening method; Trisomy.

MeSH terms

  • Adult
  • Aneuploidy
  • China
  • Congenital Abnormalities / diagnosis
  • DNA / blood
  • Down Syndrome / diagnosis
  • Female
  • Fetal Blood / chemistry
  • Gestational Age
  • Humans
  • Karyotyping
  • Maternal Age*
  • Middle Aged
  • Noninvasive Prenatal Testing / methods
  • Noninvasive Prenatal Testing / statistics & numerical data*
  • Pregnancy
  • Pregnancy, High-Risk*
  • Sensitivity and Specificity
  • Trisomy / diagnosis

Substances

  • DNA